Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells. [electronic resource]
Producer: 20071017Description: 10029-36 p. digitalISSN:- 0022-538X
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Baculoviral IAP Repeat-Containing 3 Protein
- Boronic Acids -- pharmacology
- Bortezomib
- Burkitt Lymphoma -- drug therapy
- Caspase 8 -- metabolism
- Caspase 9 -- metabolism
- Cell Line, Tumor
- Cell Transformation, Viral -- drug effects
- Herpesvirus 4, Human -- metabolism
- Humans
- Inhibitor of Apoptosis Proteins -- metabolism
- Mice
- Mice, SCID
- Multiple Myeloma -- drug therapy
- NF-kappa B p50 Subunit -- metabolism
- Proteasome Endopeptidase Complex -- metabolism
- Proteasome Inhibitors
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Pyrazines -- pharmacology
- Signal Transduction -- drug effects
- Transcription Factor RelA -- metabolism
- Ubiquitin-Protein Ligases
- Viral Matrix Proteins -- metabolism
- Virus Latency -- drug effects
- X-Linked Inhibitor of Apoptosis Protein -- metabolism
- Xenograft Model Antitumor Assays
- bcl-X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.